News

Sightec Completes First Drone Delivery Without GPS

Published

3 years ago

February 19, 2021

sightec completes first drone delivery without gps

Matrix

Some of the world’s largest retailers and e-commerce companies are actively exploring the potential of drones to deliver goods across short to medium distances. Now, Israeli startup Sightec has successfully completed its first drone delivery without GPS.

Instead of location signals provided by satellites, the drone relies on a software solution combining computer vision with artificial intelligence technologies, called NaviSight, to autonomously get to its destination.

NaviSight is compatible with all camera-equipped off-the-shelf drones. With the help of advanced video processing, the software essentially transforms the camera into a smart sensor, allowing the drone to understand its surroundings and identify its location in real-time.

“We give drones the ability to get from point A to point B safely without the need for GPS signals,” said Roy Shmuel, the CEO of Sightec. “There is no available solution today for players globally,” he added.

The test was part of a pilot program operated by Israel’s Ministry of Transport (MOT), Ayalon Highways, the Civil Aviation Authority of Israel (CAAI), and the Israel Innovation Authority. The goal of the program is to test and demonstrate the viability of autonomous drones in managed airspace.

During the test, Sightec successfully navigated the drone on five pre-determined routes near the southern city of Yeruham. “The drone completed each route safely, from take-off to full landing, over desert and construction sites,” said Shmuel.

Also Read: Apple Likely To Release 8K VR Headset In 2022

Not depending on GPS for navigation is important because GPS satellites can malfunction, and the signals transmitted by them can be disrupted by malicious hackers. Without an alternative navigation method, it would be safe to use drones for deliveries and other purposes in populated areas because they could lose signal and endanger people, buildings, and vehicles.

Shmuel also said that the test is an important step toward the legalization of drone delivery operations in Israel and other regions. However, more test flights still need to be conducted in other parts of the country before the technology is ready for prime time.

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

4 hours ago

May 7, 2024

Nour Nasir

Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.